Badger Meter heads into the back half of August with short sellers adding positions at their fastest weekly pace in months, even as the stock stabilises near a multi-month low after a brutal earnings reaction.
The short interest story is the week's defining tension. Shorts added nearly 9% in a week, pushing the position to 14.2% of the free float — a meaningful rebuild after a period of covering that had drawn the figure down roughly 6.5% over the prior month. The catalyst appears straightforward: BMI's Q2 print on July 22 sent the stock down 15.5% in a single session, and the five-day damage reached 8.5%. Bears who had trimmed into earnings are evidently re-engaging at lower levels, adding about 340,000 shares in net short exposure across the week ending August 13. The ORTEX short score has climbed to 73.2, its highest reading in the recent window, reflecting the combination of rising short interest and the stock's weak price trend.
Despite the rebuilding short position, the lending market is not under stress. Availability is running at around 167% — meaning lenders have roughly 1.67 shares available for every share already borrowed — which is tighter than the 200%-plus levels common in July but still a market with ample supply. Borrowing costs remain negligible at just over 0.5%, barely moved on the week. There is no squeeze dynamic in the making: shorts can add freely at low cost. Options positioning is similarly measured. The put/call ratio has drifted down to 1.16 from a recent peak near 1.30 in late July, now running slightly below its 20-day average of 1.20. If options traders were bracing for a second leg lower, that urgency appears to have faded — though the ratio still reflects a market that leans defensive on BMI.
The Street broadly kept its constructive ratings intact after the Q2 miss, but trimmed targets across the board. JP Morgan held its Overweight but cut the target to $170 from $172. Baird, RBC, and Stifel all maintained positive ratings while shaving between $3 and $7 off their targets. The lone dissenter, Barclays, raised its Underweight target marginally to $112 — still nearly $19 below where the stock trades, reflecting a bear case centred on slowing AMI product revenue and rising electronic component costs squeezing delivery timelines. The mean analyst target sits around $155, implying roughly 19% upside from the current $130.82 close, but that consensus is being tested by a stock that has now fallen about 7.5% in a month and sits down roughly 22% year-to-date. The valuation has re-rated accordingly: the price-to-earnings multiple has compressed to around 27x, down nearly two points from a month ago, and price-to-book has shed about 0.8 turns over the same period. Bulls point to the company's dominant position in water management and its growing high-margin software business; bears see near-term execution risk as the headwind.
One notable ownership move is worth flagging. Impax Asset Management — a specialist ESG and environmental-theme investor — appeared in the latest institutional holder data with a position of nearly 946,000 shares reported as a new holding. With BMI a natural fit for water-infrastructure mandates, the arrival of a dedicated environmental-theme manager is a reminder that the stock draws a structurally different institutional buyer than most industrial peers. On the insider side, activity is thin: a VP bought 751 shares in late July for just over $100,000, a token addition following a cluster of C-suite purchases in April when the stock was trading well below current levels. The chairman and CEO participated in that April cluster, picking up 2,200 shares near $117 — a price that now looks prescient relative to where the stock was, but less so given the post-earnings slide back toward that territory.
With Q3 results not due until October 16, the next six weeks offer little in the way of hard catalysts to resolve the debate between a 14%-short-position bear camp and a Street consensus still pointing meaningfully higher. The key variables to watch are whether the weekly short-addition pace continues or stabilises, and whether the put/call ratio moves back toward its late-July defensive highs as the earnings date approaches.
See the live data behind this article on ORTEX.
Open BMI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
